Roll over image to zoom in
Pharmaxel (Dasatinib) 20mg online
$199.00
Status: In stock
This kinase inhibitor is indicated for newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia in chronic phase. It is also indicated for adults with Ph+ CML in chronic, accelerated, or blast phase, and for adults with Ph+ acute lymphoblastic leukaemia, where there is resistance or intolerance to prior therapy including imatinib.
Dasatinib is a kinase inhibitor indicated for the treatment of
- newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
- adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.
- adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.
Related products
Recently Viewed Products
